Jennison Associates’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-383,714
Closed -$22.7M 682
2021
Q3
$22.7M Sell
383,714
-360,278
-48% -$28.3M 0.01% 343
2021
Q2
$64.6M Hold
743,992
0.04% 178
2021
Q1
$61.3M Sell
743,992
-31,365
-4% -$3.01M 0.04% 187
2020
Q4
$70.5M Sell
775,357
-240,712
-24% -$14.9M 0.05% 153
2020
Q3
$40.6M Buy
1,016,069
+3,644
+0.4% +$127K 0.03% 216
2020
Q2
$34.7M Sell
1,012,425
-106,950
-10% -$3.19M 0.03% 217
2020
Q1
$24.9M Sell
1,119,375
-187,631
-14% -$4.75M 0.03% 227
2019
Q4
$25.6M Buy
1,307,006
+7,638
+0.6% +$121K 0.03% 276
2019
Q3
$20.2M Buy
1,299,368
+751,446
+137% +$14.4M 0.02% 317
2019
Q2
$11.1M Buy
547,922
+60,878
+12% +$1.1M 0.01% 424
2019
Q1
$8.56M Buy
487,044
+253,540
+109% +$4M 0.01% 440
2018
Q4
$3M Sell
233,504
-66,496
-22% -$927K ﹤0.01% 497
2018
Q3
$4.89M Buy
+300,000
New +$3.55M ﹤0.01% 500

Other funds holding FATE